Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$11.14B net income for the year ended June 30, 2025. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| July 1, 2024 – June 30, 2025 | $51,262,000,000 | August 22, 2025 | 20-F ↗ |
| July 1, 2023 – June 30, 2024 | $55,658,000,000 | August 22, 2025 | 20-F ↗ |
| July 1, 2022 – June 30, 2023 | $53,817,000,000 | August 22, 2025 | 20-F ↗ |
| July 1, 2021 – June 30, 2022 | $65,098,000,000 | August 30, 2024 | 20-F ↗ |
| July 1, 2020 – June 30, 2021 | $56,921,000,000 | September 5, 2023 | 20-F ↗ |
| July 1, 2019 – June 30, 2020 | $38,924,000,000 | September 6, 2022 | 20-F ↗ |
| July 1, 2018 – June 30, 2019 | $44,288,000,000 | September 21, 2021 | 20-F ↗ |
| July 1, 2017 – June 30, 2018 | $43,129,000,000 | September 22, 2020 | 20-F ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: ifrs-full:Revenue · Retrieved October 8, 2026
Response SHA-256: 4b40f1150680057f69333d6bab42ed44205b5afab467d0bfddb0fe85f1ce3810
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.